rac-Ruxolitinib is the racemic analogue of Ruxolitinib (R702000). Ruxolitinib is a selective Janus tyrosine kinase (JAK1 and JAK2) inhibitor used in the treatment of myeloproliferative neoplasms and psoriasis. Molecular Formula: C17H18N6 Solubility: DMSO (Slightly), Methanol (Slightly) Molecular Weight: 306.37 Storage and Stability: Store at -20C. For maximum recovery of product, centrifuge the original vial prior to removing the cap.
Molecular Weight:
306.37
Form:
Supplied as a Pale Yellow Solid
CAS Number:
[941688-05-7]
* VAT and and shipping costs not included. Errors and price changes excepted